The dilemma of treating pyoderma gangrenosum associated with monoclonal gammopathy of undetermined significance

6Citations
Citations of this article
9Readers
Mendeley users who have this article in their library.

Abstract

Pyoderma gangrenosum (PG) is a rare ulcerative skin condition. It can be associated with a number of systemic diseases. Association with monoclonal gammopathy of undetermined significance (MGUS) is uncommon, but prognosis may be different depending upon the type of MGUS. Cases of MGUS-related PG reported in the literature with data concerning evolution and treatment were identified through a PubMed search. A patient with recurrent PG in the setting of a MGUS-lgA-A in our department was also included. In total, 10 cases were identified. Onlythe two cases with Ig populations otherthan IgA improved without recurrence after treatment of the PG. All the patients with MGUS-lgA showed recurrences. Early multiple myeloma was proposed for three patients with MGUS-lgA-related PG. Second or third line treatments were necessary in some cases.

Cite

CITATION STYLE

APA

Machan, A., Azendour, H., Frikh, R., Hjira, N., & Boui, M. (2020). The dilemma of treating pyoderma gangrenosum associated with monoclonal gammopathy of undetermined significance. Dermatology Online Journal, 26(5). https://doi.org/10.5070/d3265048791

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free